E-drug: Quality control of essential drugs (cont)
---------------------------------------------
According to GMP, a pharmaceutical manufacturer
should always have a quality control laboratory
in place equipped to perform all necessary tests
on every batch of manufactured products. This
laboratory should be independent in the sense
that the person legally responsible for drug
quality should operate directly under the
director. However, in all well functioning
pharmaceutical systems in the world the
importance of the role of independent
governmental quality monitoring next to the
quality control of the industry is beyond
question. Thus, quality control performed in
laboratories of the industry cannot function as a
sole source for quality assurance.
Moreover, the information obtained with drug
analyses is often sensitive and should be treated
as highly confidential. Therefore analyses of
products not manufactured by a company should not
be carried out within premises of this same
company.This will certainly create appearance of
independency, not to speak about the dangers of
bribe.
Margriet den Boer
Pharmacist MSF Holland
Margriet_den_Boer@amsterdam.msf.org
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.